Exited Investment
Captek Softgel
Prairie Capital Fund V
| Location | Cerritos, CA |
| Transaction Type | Growth Buyout with Founder and Management |
| Investment Date | February 2011 |
| Exit Date | December 2015 |
| Buyer | Swander Pace Capital |
| Business | FDA-compliant manufacturer and distributor of specialty softgel formulations in the nutraceutical sector to the U.S. and global markets |
| Industry | Healthcare |
Investment Rationale
- Attractive industry with strong growth opportunities
- Experienced, equity incentivized management team
- Recurring Revenue from diversified, blue chip, branded vitamin and supplement companies
- Competitive advantage through cGMP compliance
- Established distribution presence in Asian markets
Value Add
- Human Capital
- Sales & Marketing
- Technology
- Infrastructure
- New Products
TEAM:
Working with Prairie was truly a partnership rather than an investor relationship. Even when things weren’t going smoothly they remained steadfast and supportive and ended every call by asking ‘if there was anything they could do to help.’ Their experience working in the lower middle market was invaluable by providing me with context and advice from their years of experience acquiring businesses from the founders and entrepreneurs and the idiosyncrasies that come with those transactions. I would love to work with the Prairie team again and hope to someday.